Carregant...
Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases
BACKGROUND: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...
Guardat en:
| Publicat a: | Kidney Dis (Basel) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089424/ https://ncbi.nlm.nih.gov/pubmed/34192120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515278 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|